Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Spencer

Showing results (21-30 of 111) with videos related to

Pageof 12
Sort By:
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 18, 2009
AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequencesKip Bodi, Tatiana Prokaeva, Brian Spencer, et al.
The Journal of Biological Chemistry|May 15, 2014
A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesisBrian Spencer, Inder Verma, Paula Desplats, et al.
ACS Chemical Neuroscience|February 7, 2023
<b>D-685</b> Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson's Disease Animal ModelsAloke K Dutta, Christopher Armstrong, Dan Luo, et al.
The Journal of Biological Chemistry|December 2, 2015
Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer DiseaseBrian Spencer, Rewati Potkar, Jeff Metcalf, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 25, 2015
Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literatureShayna Sarosiek, David C Seldin, Lawreen H Connors, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2012
Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Neurobiology of Disease|September 10, 2023
Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's diseaseAndré D G Leitão, Rijwan U Ahammad, Brian Spencer, et al.
Journal of Neurochemistry|February 6, 2008
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's diseasePazit Bar-On, Leslie Crews, Andrew O Koob, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 29, 2016
Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratioTatiana Prokaeva, Brian Spencer, Fangui Sun, et al.
Arthritis and Rheumatism|October 31, 2007
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survivalTatiana Prokaeva, Brian Spencer, Maurya Kaut, et al.
Pageof 12

Showing results (21-30 of 111) with videos related to

Sort By:
Pageof 12
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 18, 2009
AL-Base: a visual platform analysis tool for the study of amyloidogenic immunoglobulin light chain sequencesKip Bodi, Tatiana Prokaeva, Brian Spencer, et al.
The Journal of Biological Chemistry|May 15, 2014
A neuroprotective brain-penetrating endopeptidase fusion protein ameliorates Alzheimer disease pathology and restores neurogenesisBrian Spencer, Inder Verma, Paula Desplats, et al.
ACS Chemical Neuroscience|February 7, 2023
<b>D-685</b> Reverses Motor Deficits and Reduces Accumulation of Human α-Synuclein Protein in Two Different Parkinson's Disease Animal ModelsAloke K Dutta, Christopher Armstrong, Dan Luo, et al.
The Journal of Biological Chemistry|December 2, 2015
Systemic Central Nervous System (CNS)-targeted Delivery of Neuropeptide Y (NPY) Reduces Neurodegeneration and Increases Neural Precursor Cell Proliferation in a Mouse Model of Alzheimer DiseaseBrian Spencer, Rewati Potkar, Jeff Metcalf, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|June 25, 2015
Vertebral compression fractures as the initial presentation of AL amyloidosis: case series and review of literatureShayna Sarosiek, David C Seldin, Lawreen H Connors, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 18, 2012
Lentivirus mediated delivery of neurosin promotes clearance of wild-type α-synuclein and reduces the pathology in an α-synuclein model of LBDBrian Spencer, Sarah Michael, Jay Shen, et al.
Neurobiology of Disease|September 10, 2023
Novel systemic delivery of a peptide-conjugated antisense oligonucleotide to reduce α-synuclein in a mouse model of Alzheimer's diseaseAndré D G Leitão, Rijwan U Ahammad, Brian Spencer, et al.
Journal of Neurochemistry|February 6, 2008
Statins reduce neuronal alpha-synuclein aggregation in in vitro models of Parkinson's diseasePazit Bar-On, Leslie Crews, Andrew O Koob, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|September 29, 2016
Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratioTatiana Prokaeva, Brian Spencer, Fangui Sun, et al.
Arthritis and Rheumatism|October 31, 2007
Soft tissue, joint, and bone manifestations of AL amyloidosis: clinical presentation, molecular features, and survivalTatiana Prokaeva, Brian Spencer, Maurya Kaut, et al.
Pageof 12